Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

NCT02205489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Alemtuzumab GZ402673
DRUG: cetirizine
DRUG: ranitidine
DRUG: methylprednisolone
DRUG: methylprednisolone
DRUG: aciclovir
DRUG: esomeprazole
DRUG: ibuprofen
DRUG: paracetamol

Sponsor

Genzyme, a Sanofi Company